The Journal of Neuroscience, September 2, 2009, 29(35):11029-11037; doi:10.1523/JNEUROSCI.1653-09.2009
Previous Article | Next Article 
Behavioral/Systems/Cognitive
The Effects of Caffeine on Sleep in Drosophila Require PKA Activity, But Not the Adenosine Receptor
Mark N. Wu,1 *
Karen Ho,2 *
Amanda Crocker,2
Zhifeng Yue,3
Kyunghee Koh,2 and
Amita Sehgal2,3
1Division of Sleep Medicine, Department of Neurology, 2Department of Neuroscience, and 3Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Correspondence should be addressed to Amita Sehgal, Department of Neuroscience/University of Pennsylvania, 232 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104. Email: amita{at}mail.med.upenn.edu
Caffeine is one of the most widely consumed stimulants in the world and has been proposed to promote wakefulness by antagonizing function of the adenosine A2A receptor. Here, we show that chronic administration of caffeine reduces and fragments sleep in Drosophila and also lengthens circadian period. To identify the mechanisms underlying these effects of caffeine, we first generated mutants of the only known adenosine receptor in flies (dAdoR), which by sequence is most similar to the mammalian A2A receptor. Mutants lacking dAdoR have normal amounts of baseline sleep, as well as normal homeostatic responses to sleep deprivation. Surprisingly, these mutants respond normally to caffeine. On the other hand, the effects of caffeine on sleep and circadian rhythms are mimicked by a potent phosphodiesterase inhibitor, IBMX (3-isobutyl-1-methylxanthine). Using in vivo fluorescence resonance energy transfer imaging, we find that caffeine induces widespread increase in cAMP levels throughout the brain. Finally, the effects of caffeine on sleep are blocked in flies that have reduced neuronal PKA activity. We suggest that chronic administration of caffeine promotes wakefulness in Drosophila, at least in part, by inhibiting cAMP phosphodiesterase activity.
Received April 6, 2009;
revised July 22, 2009;
accepted July 23, 2009.
Correspondence should be addressed to Amita Sehgal, Department of Neuroscience/University of Pennsylvania, 232 Stemmler Hall, 3450 Hamilton Walk, Philadelphia, PA 19104. Email: amita{at}mail.med.upenn.edu